explore -WSS

explore

author：entertainment 2025-09-03 14:37:55 - browse：2218

Illustration of two DNA strands made of banknotes. -- health coverage from STAT — Adobe

The staff of the Institute for Clinical and Economic Review, or ICER, are known as the nerds of the drug industry: bespectacled killjoys who emerge a few times a year to scold drugmakers for pricing their latest cancer or MS advance far beyond reason.

But last year, they sat down and concluded a forthcoming treatment was worth up to $3.9 million — more than any medicine in history, more than a 45-year supply of Humira, the autoimmune drug often held up as an emblem of America’s runaway drug spending.

It was a testament to the power of a new class of gene therapies to deliver something pharma so rarely does: Genuine cures. The treatment, approved last week as Lenmeldy, may allow some babies born with an ultra-rare neurodegenerative disease called metachromatic leukodystrophy, or MLD, to grow up and live essentially normal lives.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

WSS

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Listen: More tumult at BIO & coercive care for sickle cell patients

Senate panel eyes new effort on drug shortages

ASCO eve: Let’s set the table for this year's meeting

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Investigation reveals sickle cell patients pressured into sterilizations

knowledge

explore

entertainment

How one medical school became remarkably diverse

When women are denied an abortion, their children fare worse than peers

As demand for Covid shots wanes, Moderna seeks its next success

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Jerome Adams on the need for new antivirals for Covid

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Hollywood unions extend contract negotiations for actors

A virus, fished out of a lake, may have saved a man’s life

Psychedelics group wrestles with new pharma identity

Cue Health, Covid

explore

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Liquid biopsy for lung cancer is launched by Delfi

At flashy new research hub, AstraZeneca lays out ambitious growth goals

FDA panel signals lack of confidence in Amgen cancer drug data

AI can decode, harness the power of the humane immune system

Analysis of telehealth claims data suggest service duplication

hotspot

focus

entertainment

knowledge